SEC 13F Intelligence

Boxer Capital, LLC / MRNSUSD

Boxer Capital, LLC’s Marinus Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Marinus Pharmaceuticals Inc (MRNSUSD)? Not currently — the last reported position was 9.60M shares worth $24M in Q2 2020; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$24M
Q2 2020
Shares
9.60M
% of Portfolio
+1.07%
Quarters Held
3
position exited

Position History MRNSUSD

Reported value by quarter
Q4 ’19: $10MQ4 ’19Q1 ’20: $10MQ1 ’20Q2 ’20: $24MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20209.60M$24M+1.07%
Q1 20204.80M$10M+0.66%
Q4 20194.80M$10M+0.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of MRNSUSD.